PVLA
Palvella Therapeutics Inc

212
Mkt Cap
$965.15M
Volume
187,296.00
52W High
$114.69
52W Low
$17.31
PE Ratio
-6.47
PVLA Fundamentals
Price
$81.54
Prev Close
$82.02
Open
$81.76
50D MA
$92.79
Beta
0.94
Avg. Volume
228,582.30
EPS (Annual)
-$7.83
P/B
23.37
Rev/Employee
$0.00
$44.95
Loading...
Loading...
News
all
press releases
Federated Hermes Inc. Takes $21.26 Million Position in Palvella Therapeutics, Inc. $PVLA
Federated Hermes Inc. acquired a new stake in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 339,047...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
Kathleen Goin Sells 4,302 Shares of Palvella Therapeutics (NASDAQ:PVLA) Stock
Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) COO Kathleen Goin sold 4,302 shares of the business's stock in a transaction that occurred on Wednesday, January 21st. The shares were sold...
MarketBeat·23d ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Stock Price Down 7.8% - Here's Why
Palvella Therapeutics (NASDAQ:PVLA) Trading Down 7.8% - Should You Sell...
MarketBeat·23d ago
News Placeholder
Palvella Therapeutics, Inc. (NASDAQ:PVLA) Receives Average Recommendation of "Buy" from Analysts
Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) has been assigned an average recommendation of "Buy" from the eighteen brokerages that are currently covering the company, MarketBeat...
MarketBeat·28d ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Earns Buy Rating from BTIG Research
BTIG Research restated a "buy" rating and issued a $192.00 target price on shares of Palvella Therapeutics in a research report on Friday...
MarketBeat·1mo ago
News Placeholder
Palvella Therapeutics, Inc. (NASDAQ:PVLA) Short Interest Up 60.9% in December
Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totaling 1,326,830...
MarketBeat·1mo ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Stock Price Down 4.9% - Here's What Happened
Palvella Therapeutics (NASDAQ:PVLA) Shares Down 4.9% - What's Next...
MarketBeat·1mo ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Trading Up 3.9% - Should You Buy?
Palvella Therapeutics (NASDAQ:PVLA) Shares Up 3.9% - Time to Buy...
MarketBeat·2mo ago
News Placeholder
Palvella Therapeutics, Inc. (NASDAQ:PVLA) Receives Average Recommendation of "Buy" from Analysts
Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) has earned an average rating of "Buy" from the seventeen brokerages that are currently covering the company, Marketbeat reports. One...
MarketBeat·2mo ago
News Placeholder
Palvella Therapeutics, Inc. (NASDAQ:PVLA) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) have received an average recommendation of "Buy" from the seventeen ratings firms that are covering the firm, Marketbeat.com...
MarketBeat·2mo ago
<
1
2
...
>

Latest PVLA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.